Eli Lilly and Company
礼来
Eli Lilly and Company is a global pharmaceutical multinational that appears in elsewhere's coverage primarily through its partnership activity in China. The drug maker has collaborated with Nanjing-based Triastek, a 3D-printed drug startup, on product and technology-solution partnerships since at least 2023 . Triastek's deal roster also names Boehringer Ingelheim, Merck, Siemens, and Sperogenix alongside Lilly . Separately, Xiaodu Lou, founder of women's-health startup Lollitech, worked at Eli Lilly before founding her company in 2015 . elsewhere's corpus does not cover Lilly's founding, headquarters, or broader corporate history.
AI-generated — may contain errors, please verify.
Coverage
Over $1.2 Billion in Total Value: Triastek Announces First-Ever Technology Platform International Collaboration in Chinese Pharmaceutical History with BioNTech | Yunqi Capital
Empowering Digital Transformation in Pharmaceutical Development
云启资本·"Triastek" Closes 150 Million Yuan Pre-C Round to Accelerate Commercialization of 3D-Printed Drugs | Yunqi Capital
Pioneering a New Era of Intelligent Drug Discovery
云启资本·How Can a "3D Printer" Boost Productivity in the Pharmaceutical Industry? | The B-Side of Entrepreneurship
Take the hard, meaningful path
云启资本·
